|View printer-friendly version|
“We are delighted to be hosting another CAP Meeting with our PACE Medical Directors,” said CareKinesis President, Orsula V. Knowlton, PharmD, MBA. “This annual meeting is a great opportunity for our Clinical Pharmacists to interact with the Medical Directors, ensuring we are collaborating to improve patient outcomes and benefit our PACE participants.”
Topics that will be discussed during the two-day meeting include:
Additionally, new Medical Directors will receive a separate orientation on pharmacodynamics and pharmacokinetics and how these pharmacology branches impact patient medication use. All participants will receive continuing education credits for attending the educational sessions.
Presentations from TRHC and CareKinesis staff will examine different strategies for improving the identification of medication interactions. TRHC Chief Scientific Officer, Jacques Turgeon, BPharm, PhD, will discuss the concepts of risk stratification and risk scoring, and will compare models currently utilized in the healthcare system. CareKinesis Vice President for Medication Risk Mitigation, Kevin Bain, PharmD, MPH, will focus on the misuse/overuse of antipsychotic medications.
Robert Straka, PharmD, Department Chair and Professor,
PACE organizations nationwide rely on CareKinesis to improve medication safety and adherence and to reduce hospitalizations and recidivism. CareKinesis accomplishes this through prospective, geriatric-trained and board-certified pharmacist medication management services in collaboration with PACE prescribers, a proprietary electronic medication platform that includes its Medication Risk Mitigation Matrix®, adherence packaging choices and flexible medication access options. CareKinesis formed CAP as a physician-user group comprised of client Medical Directors and/or their designees.
CareKinesis partners with healthcare organizations to provide personalized medication therapy management and pharmacy services for high-risk populations. The results are enhanced medication-related outcomes and greater operational efficiency.